R De Bock - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R De Bock

Showing results (31-40 of 40) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 40 results.

Antimicrobial Agents and Chemotherapy|February 1, 1995

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerA Cometta, S Zinner, R de Bock, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994

EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphomaR Somers, P Carde, J Thomas, et al.

The Journal of Antimicrobial Chemotherapy|June 22, 2001

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.

Acta Clinica Belgica|January 1, 1992

Large granular lymphocyte proliferative disease: 21 Belgian cases and review of the literatureP G Pierre, A Bosly, R De Bock, et al.

Leukemia|May 1, 1988

Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemiaZ N Berneman, D R van Bockstaele, M Van den Bergh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998

Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative GroupA Hagenbeek, P Carde, J H Meerwaldt, et al.

Antimicrobial Agents and Chemotherapy|June 20, 2000

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin BJ L Harousseau, A W Dekker, A Stamatoullas-Bastard, et al.

European Journal of Cancer (Oxford, England : 1990)|June 5, 2004

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasisA M L Oude Lashof, R De Bock, R Herbrecht, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1996

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection ProgramA Cometta, T Calandra, H Gaya, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapyA Cometta, W V Kern, R De Bock, et al.

Pageof 4

Search research articles

Showing results (31-40 of 40) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 40 results.

Antimicrobial Agents and Chemotherapy|February 1, 1995

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994

The Journal of Antimicrobial Chemotherapy|June 22, 2001

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patientsM Boogaerts, J Maertens, A van Hoof, et al.

Acta Clinica Belgica|January 1, 1992

Large granular lymphocyte proliferative disease: 21 Belgian cases and review of the literatureP G Pierre, A Bosly, R De Bock, et al.

Leukemia|May 1, 1988

Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemiaZ N Berneman, D R van Bockstaele, M Van den Bergh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998

Antimicrobial Agents and Chemotherapy|June 20, 2000

European Journal of Cancer (Oxford, England : 1990)|June 5, 2004

Antimicrobial Agents and Chemotherapy|May 1, 1996

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapyA Cometta, W V Kern, R De Bock, et al.

Pageof 4